DETAILS, FICTION AND MELANOMA PEMBROLIZUMAB

This prevents the activation from the T-cell which normally would target and ruin cancer. The cancer cells can then multiply and spread. When Keytruda binds on the PD-one receptor it stops cancer cells from linking to and inactivating T-cells, allowing T-cell re-activation, and boosting the immune system's response against cancer. This affects the